Atenolol
- Product NDC
- 68071-4527
- 11-digit product format
- 680714527
- Labeler code
- 68071
- Product ID
- 68071-4527_1a90935a-6f79-0b01-e063-6394a90a983f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atenolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA077443
- Marketing category
- ANDA
- Marketing start
- 2010-06-10
- Substance
- ATENOLOL
- Active strength
- 50 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atenolol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ATENOLOL | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 50VV3VW0TI |
| Rxcui | 197381 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 68071-4527-1 | 2024-06-10 | C162847 | 48780-1 | f386c64a-3bfc-0266-e053-dadaa90a7c1a | Atenolol Tablets USP 25 mg, 50 mg and 100 mg |
| 68071-4527-3 | 2024-06-10 | C162847 | 48780-1 | f386c64a-3bfc-0266-e053-dadaa90a7c1a | Atenolol Tablets USP 25 mg, 50 mg and 100 mg |
| 68071-4527-6 | 2024-06-10 | C162847 | 48780-1 | f386c64a-3bfc-0266-e053-dadaa90a7c1a | Atenolol Tablets USP 25 mg, 50 mg and 100 mg |
| 68071-4527-9 | 2024-06-10 | C162847 | 48780-1 | f386c64a-3bfc-0266-e053-dadaa90a7c1a | Atenolol Tablets USP 25 mg, 50 mg and 100 mg |
| 68071-4527-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3bfc-0266-e053-dadaa90a7c1a | Atenolol Tablets USP 25 mg, 50 mg and 100 mg |
| 68071-4527-3 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3bfc-0266-e053-dadaa90a7c1a | Atenolol Tablets USP 25 mg, 50 mg and 100 mg |
| 68071-4527-6 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3bfc-0266-e053-dadaa90a7c1a | Atenolol Tablets USP 25 mg, 50 mg and 100 mg |
| 68071-4527-9 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3bfc-0266-e053-dadaa90a7c1a | Atenolol Tablets USP 25 mg, 50 mg and 100 mg |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-4527-1 | Atenolol | 120 in 1 BOTTLE | TABLET | 120 | | 6 |
| 68071-4527-3 | Atenolol | 30 in 1 BOTTLE | TABLET | 30 | | 6 |
| 68071-4527-6 | Atenolol | 60 in 1 BOTTLE | TABLET | 60 | | 6 |
| 68071-4527-9 | Atenolol | 90 in 1 BOTTLE | TABLET | 90 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-4527 | ATENOLOL TABLET [NUCARE PHARMACEUTICALS,INC.] | 6 | Current NDC, Legacy NDC, 4 package rows | 20240612_73671d55-3e10-cb1d-e053-2991aa0ac038.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-4527-1 | 68071452701 | 120 TABLET in 1 BOTTLE (68071-4527-1) | 120 tablet | 2018-08-14 | 0000-00-00 | No | No | Current |
| 68071-4527-3 | 68071452703 | 30 TABLET in 1 BOTTLE (68071-4527-3) | 30 tablet | 2018-08-14 | 0000-00-00 | No | No | Current |
| 68071-4527-6 | 68071452706 | 60 TABLET in 1 BOTTLE (68071-4527-6) | 60 tablet | 2018-08-14 | 0000-00-00 | No | No | Current |
| 68071-4527-9 | 68071452709 | 90 TABLET in 1 BOTTLE (68071-4527-9) | 90 tablet | 2018-08-14 | 0000-00-00 | No | No | Current |